Asset Details
Do you wish to reserve the book?
Vedolizumab for the Treatment of Chronic Pouchitis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Vedolizumab for the Treatment of Chronic Pouchitis
Do you wish to request the book?
Vedolizumab for the Treatment of Chronic Pouchitis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Vedolizumab for the Treatment of Chronic Pouchitis
2023
Overview
In a phase 4, double-blind, randomized trial, vedolizumab therapy was more effective than placebo in inducing remission in patients with chronic pouchitis after ileal pouch–anal anastomosis for ulcerative colitis.
Publisher
Massachusetts Medical Society
Subject
/ Adult
/ Allergy
/ Anti-Bacterial Agents - administration & dosage
/ Anti-Bacterial Agents - therapeutic use
/ Antibodies, Monoclonal, Humanized - administration & dosage
/ Antibodies, Monoclonal, Humanized - therapeutic use
/ Ciprofloxacin - administration & dosage
/ Ciprofloxacin - therapeutic use
/ Colitis, Ulcerative - complications
/ Colitis, Ulcerative - surgery
/ Feces
/ Gastrointestinal Agents - administration & dosage
/ Gastrointestinal Agents - therapeutic use
/ Humans
/ Patients
/ Placebos
/ Proctocolectomy, Restorative - adverse effects
/ Surgery
